|
|
|
Pretransfusion
Last updated: 23 Oct. 2009
TraQ clearinghouse for pretransfusion literature and news
Other
literature clearinghouses:
Adverse events
| Economics of
transfusion |
Quality systems |
Technology to enhance safety |
TM in developing countries
. . . . . . . . . . . . . . . . . . . . . . . . . .
Key: Full text
Specimen collection, identification, and labelling
Antibody detection and identification
Compatibility testing (crossmatch)
Specimen
collection, identification, and labelling
Callum JL, Kaplan HS, Merkley LL, Pinkerton PH, Rabin Fastman B, Romans RA, et al. Reporting of near–miss events for transfusion medicine: improving transfusion safety. Transfusion 2001 Oct;41(10):1204–11. [ Medline ]
CBBS e–Network Forum: Preventing pre-transfusion specimen labeling errors (Jan. 30, 2002)
Cummins D, Sharp
S, Vartanian M, et al. The BSCH guideline on addressograph
labels: experience at a cardiothoracic unit and findings of a
telephone survey. Transfus Med 2000;10:117–20.
Sharp
S, Cummins DV. The BSCH guideline on addressograph
labels: an update (letter).
Transfus Med 2001 Jun;11(3):221
Lau FY, Wong R,
Chui CH, et al. Improvement in transfusion safety using a
specially designed transfusion wristband. Transfus Med
2000;10:121–4.
Linden JV. Errors in transfusion medicine. scope of the problem. Arch Pathol Lab Med 1999 ;123(7): 563–5.
Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion 2000;40(10):1207–13. [ Medline ]
Lumadue JA, Boyd JS, Ness PM. Adherence to a strict specimen-labeling policy decreases the incidence of erroneous blood grouping of blood bank specimens. Transfusion 1997 Nov–Dec;37(11–12):1169–72. [ Medline ]
Mercuriali F,
Inghilleri G, Colotti MT, et al. Bedside transfusion errors:
analysis of 2 years' use of a system to monitor and prevent
transfusion errors. Vox Sang 1996;70:16–20.
Myhre BA, McRuer D. Human error–a significant cause of transfusion mortality. Transfusion 2000 Jul;40(7):879–85. [Medline ]
Pagliaro P, Rebulla P. Transfusion recipient identification. Vox Sang 2006; 91(2):97–101.
Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J 1999;319:16–9. Br Med J 1999;319:16–9.
Antibody
detection and identification methods
Bunker ML, Thomas CL, Geyer SJ. Optimizing pretransfusion antibody detection and identification: a parallel, blinded comparison of tube PEG, solid–phase, and automated methods. Transfusion 2001 May;41(5):621–6. [ Medline ]
CBBS e-Forum. PEG versus LISS. California Blood Bank Society website (2001)
Judd WJ, Barnes BA, Steiner EA, Oberman HA, Averill DB, Butch SH. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited. Transfusion 1986 May–Jun;26(3):220–4. [ Medline ]
Judd WJ, Fullen DR, Steiner EA, Davenport RD, Knafl PC. Revisiting the issue: can the reading for serologic reactivity following 37 degrees C incubation be omitted? Transfusion 1999 Mar;39(3):295–9. [ Medline ]
Judd WJ, Steiner EA, Knafl PC. The gel test: sensitivity and specificity for unexpected antibodies to blood group antigens. Immunohematology 1997;13:132–5. [ abstract ]
Morelati F, Revelli N, Maffei LM, Poretti M, Santoro C, Parravicini A, et al. Evaluation of a new automated instrument for pretransfusion testing. Transfusion 1998 Oct;38(10):959–65. [ Medline ]
Polski JM, Creer MH, Ritter D, Johnston MFM. Polyethylene glycol–induced immunoglobulin precipitation may cause invalidation of antiglobulin tests.Transfusion 1999 May;39(5) 537–8. [ Medline ]
Rumsey DH,
Ciesielski DJ.
New protocols in serologic testing: a review
of techniques to meet today’s challenges. Immunohematolgy 2000; 16(4)
Sandler SG, Langeberg A, Avery N, Mintz PD. A fully automated blood typing system for hospital transfusion services. ABS2000 Study Group. Transfusion 2000 Feb;40(2):201–7. [ Medline ]
hin SY, Kwon KC, Koo SH, Park JW, Ko CS, Song JH, Sung JY. Evaluation of two automated instruments for pre-transfusion testing: AutoVue Innova and Techno TwinStation. Korean J Lab Med 2008 Jun;28(3):214–20.
Shirey RS, Boyd JS, Ness PM. Polyethylene glycol versus low–ionic–strength solution in pretransfusion testing: a blinded comparison study. Transfusion 1994;34:368–70. [ Medline ]
Slater JL, Griswold DJ, Wojtyniak LS, Reisling MJ. Evaluation of the polyethylene glycol-potentiated indirect antiglobulin test for routine compatibility testing. Transfusion 1989;29:686–8.
Weisbach V, Kohnhäuser T, Zimmermann R, Ringwald J, Strasser E, Zingsem J, Eckstein R. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med 2006 Aug; 16(4): 276–84.
Yazer MH. The blood bank "black box" debunked: pretransfusion testing explained. CMAJ 2006;174(1): 29–32.
Yazer MH, Triulzi DJ.
The role of the elution in antibody investigations.
Transfusion 2009 Nov;49(11): 2395–9.
Compatibility
testing (crossmatch)
UK: Guidelines for compatibility procedures in blood transfusion laboratories
Butch SH, Oberman HA. The computer or electronic crossmatch. Transfus Med Rev. 1997 Oct;11(4):256–64.
CBBS e–Forum. Experience with electronic crossmatch. California Blood Bank Society website (2001)
Chapman JF, Milkins C, Voak D. The computer crossmatch: a safe alternative to the serological crossmatch. Transfus Med 2000 Dec;10(4):251–6. [ Medline ]
Connolly M, Erber WN, Grey DE. Case report: immune anti-D stimulated by transfusion of fresh frozen plasma. Immunohematol 2005;21(4):149–51.
Dietz G. Is the antiglobulin crossmatch a necessary part of the pretransfusion testing? Victoria Hospital. London, Ontario.
Engelfreit CP, Reesink HW, Krusius T, Wendel S, Fontao-Wendel R, Hoffer I, et al. The use of the computer cross-match (International Forum). Vox Sang. 2001 Apr;80(3):184–92.
FDA.
Draft
Guideline for the Validation of Blood Establishment Computer
Systems, including
validation
FDA. General Principles of SoftwareValidation; Final Guidance for Industry and FDA Staff
Judd WJ. Requirements for the electronic crossmatch. Vox Sang 1998;74 Suppl 2:409–17. [ Medline ]
Maffei LM, Johnson ST, Shulman IA, Steiner EA. Survey on pretransfusion testing. Transfusion 1998 Apr;38(4):343–9. [Medline ]
Lee E, Burgess G, Win N. Autoimmune hemolytic anemia and a further example of autoanti-Kpb. Immunohematol 2005;21(3):119–21.
Zarandona JM, Yazer MH. The role of the Coombs test in evaluating hemolysis in adults (Teaching Case Report). CMAJ 2006 Jan 31;174:305-7.
Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. Br Med J 1999;319:16–9.
Ou CY, Chiou YH, Chang JT, Chiu CL, Shih CH, Hsieh KS. Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection: report of one case. Acta Paediatr Taiwan 2005 Nov-Dec;46(6):381–4.
Byers BD, Gordon MC, Higby K. Severe hemolytic disease of the newborn due to anti-Cw. Obstet Gynecol 2005 Nov;106(5 Pt 2):1180–2.
Dinesh D. Review of positive direct antiglobulin tests found on cord blood sampling. J Paed Child Health 2005 Sep;41(9-10):504–7.
Lydaki E, Nikoloudi I, Kaminopetros P, Bolonaki I, Sifakis S, Kikidi K, et al. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku. Transfusion 2005 Nov;45(11):1791–5.
Trevett TN Jr, Moise KJ Jr. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-G and anti-C. Obstet Gynecol 2005 Nov;106(5 Pt 2):1178–80.
Van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget-Christiaens LG, de Haas M. Non-invasive antenatal RHD typing. Transfus Clin Biol. 2006 Mar-Apr;13(1-2):53–7.
Cardigan R, Smith K. Evaluation of the HemoCue plasma haemoglobin analyser for assessing haemolysis in red cell concentrates during storage. Vox Sang 2002 Feb;82(2):76–9. [ Medline ]
Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev. 2001 Apr;15(2):91–107.
George VM, Pringle TC, Kline L, Friedman LI. Development and evaluation of a shipping system for platelet components. Transfusion 1996 Apr;36(4):335–8. [Medline]
Moore SB, Foss ML. Error management: Theory and application in transfusion medicine at a tertiary–care institution Arch Pathol Lab Med 2003;127(11):1517–22.
Rentas FJ, Macdonald VW, Houchens DM, Hmel PJ, Reid TJ. New insulation technology provides next–generation containers for "iceless" and lightweight transport of RBCs at 1 to 10 degrees C in extreme temperatures for over 78 hours. Transfusion 2004 Feb;44(2):210–6. [Medline ]
Sharley PH, Williams I, Hague S. Blood transportation for medical retrieval services. Air Med J 2003 Nov–Dec;22(6):24–7. (validation of blood transport containers in Australia) [Medline]
Online Resources:
B.C. Provincial Blood Coordinating Office (PBCO) inter–hospital redistribution program.
Sample SOPs for blood product transportation (Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada)
- Guidelines for blood product packing for transport between sites
- Guidelines for transfer of blood components and blood products
- Blood transport within the hospital in a cooler
TraQ Case A7: Inter–facility transportation of RBCs
Transfusion Ontario –Sample work aid for blood product transportation
Roth VR, Arduino MJ, Nobiletti J, Holt SC, Carson LA, Wolf CF, et al. Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion 2000 Aug;40(8):931–5. [ Medline ]
Copyright © 2002 - 2010 TraQ Program of the British Columbia Provincial Blood Coordinating Office, a program of the Provincial Health Services Authority. All rights reserved.
![]() |
PHSA improves the health of British Columbians by seeking province-wide solutions to specialized health care needs in collaboration with BC health authorities and other partners. For more information, visit www.phsa.ca |
| PHSA agencies include: BC Cancer Agency, BC Centre for Disease Control, BC Children’s Hospital and Sunny Hill Health Centre for Children, BC Mental Health & Addiction Services, BC Provincial Renal Agency, BC Transplant, BC Women’s Hospital & Health Centre, and Cardiac Services BC. | |